NUCLEOLAR ORGANIZER REGIONS (AGNOR) AND KI-67 IMMUNOREACTIVITY IN CUTANEOUS MELANOCYTIC LESIONS

被引:32
|
作者
FOGT, F
VORTMEYER, AO
TAHAN, SR
机构
[1] NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
[2] BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA
[3] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA
关键词
DYSPLASTIC NEVUS; MELANOCYTIC LESIONS; MELANOMA; AGNOR; NUCLEOLAR ORGANIZER REGION; KI-67; MIB-1;
D O I
10.1097/00000372-199502000-00003
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
A stepwise schema for the developmental biology of malignant melanomas has been proposed. In this study, two properties associated with malignant transformation-AgNOR production and Ki-67 immunoreactivity-were tested on a series of lesions representative of this model. Fourteen ordinary nevi (N), seven dysplastic nevi (DN), 12 radial growth phase melanomas (RGPM), and eight vertical growth phase melanomas (VGPM) were stained for AgNORs; Ki-67 immunoreactivity was determined in paraffin sections after antigen retrieval. AgNORs averaged 2.1 in N, 3.8 in DN, 5.4 in RGPM, and 7.3 in VGPM (p < 0.001 between all groups), Ki-67 immunoreactivity averaged <1 in nevi, 1.6 in dysplastic nevi, 23.3 in RGPM, and 20.1 in VGPM. No difference was observed between N and DN, and RGPM/VGPM had higher Ki-67 indices than N/DN (p < 0.01). Stepwise increases in cellular AgNORs parallel the melanocytic progression model and thereby corroborate the intermediate nature of the dysplastic nevus. The order of magnitude increase in Ki-67 immunoreactivity observed in RGP and VGP melanomas compared with N and DN likely reflects the onset of loss of cell cycle control in these lesions.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 50 条
  • [31] IMPROVEMENTS IN THE SILVER-STAINING TECHNIQUE FOR NUCLEOLAR ORGANIZER REGIONS (AGNOR)
    LINDNER, LE
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1993, 41 (03) : 439 - 445
  • [32] Argyrophilic nucleolar organizer regions (AgNOR) of resected intrahepatic cholangiocellular carcinomas
    Hayashi, H
    Maeda, T
    Adachi, E
    Shimada, M
    Matsumata, T
    Takenaka, K
    HEPATO-GASTROENTEROLOGY, 1995, 42 (05) : 440 - 444
  • [33] NUCLEOLAR ORGANIZER REGIONS IN IRIS MELANOCYTIC TUMORS - AN ACCURATE PREDICTOR
    DEUBLE, K
    MCCARTNEY, A
    EYE, 1990, 4 : 743 - 750
  • [34] Nucleolar organizer regions in selected odontogenic lesions
    Eslami, B
    Yaghmaei, M
    Firoozi, M
    Saffar, AS
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2003, 95 (02): : 187 - 192
  • [35] REEVALUATING SILVER-STAINED NUCLEOLAR ORGANIZER REGIONS (AGNORS) IN PROBLEMATIC CUTANEOUS MELANOCYTIC LESIONS - A STUDY WITH QUANTITATION AND PATTERN-ANALYSIS
    EVANS, AT
    ORRELL, JM
    GRANT, A
    JOURNAL OF PATHOLOGY, 1991, 165 (01): : 61 - 67
  • [36] NUCLEOLAR ORGANIZER REGIONS IN CEREBRAL-LESIONS
    OLINICI, CD
    ISBAITA, E
    POP, C
    RASINARU, A
    CANCER JOURNAL - FRANCE, 1991, 4 (01): : 58 - 60
  • [37] PCNA and Ki-67 immunoreactivity in ameloblastomas.
    Meer, S
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A407 - A407
  • [38] PCNA and Ki-67 immunoreactivity in ameloblastomas.
    Meer, S
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : B369 - B369
  • [39] SEQUENTIAL DEMONSTRATION OF NUCLEOLAR ORGANIZER REGIONS AND KI67 IMMUNOLABELLING IN NON-HODGKINS-LYMPHOMAS
    JANMOHAMED, RMI
    MURRAY, PG
    CROCKER, J
    LEYLAND, MJ
    CLINICAL AND LABORATORY HAEMATOLOGY, 1990, 12 (04): : 395 - 399
  • [40] A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions
    Li, LXL
    Crotty, KA
    McCarthy, SW
    Palmer, AA
    Kril, JJ
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2000, 22 (06) : 489 - 495